med student here: Reducing immunosuppressant not something to be taken lightly for kidney transplant patients. I was shocked when I read that sentence.
this is pubmed. Most papers that are funded by NIH research are available on pubmed if the main publisher gives access to the full text (after some set embargo period...usually around a year).
It's just about taking a bet. I'm sure that magic leap must have had some demo (perhaps rehearsed) of a rudimentary alpha version they showed investors that was enough to convince people it was possible. From an investor standpoint, there isn't much downside outside of losing money. But the potential upside would have been huge.